MiNA Therapeutics

0 followers


Harnessing an innate mechanism of gene activation, MiNA Therapeutics'​ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.

Industries

Employees

11-50

Links

Org chart

Robert Habib Mba

Collapse
Robin Wright
Group Chief Financial Officer
Peter Bains
Chief Business Officer
Bríd Ryan
SVP, Research